---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042196"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-09-10T20:35:30+00:00"
generated_at: "2026-09-10T20:37:10.415309+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech converts $450K of promissory note into 1.92M shares at $0.234/share

## Summary
- Entered two exchange agreements with Streeterville Capital on Sept 3-4, 2026, converting ~$450,000 of Nov 2025 promissory note.
- Issued 1,921,441 common shares at average conversion price of ~$0.234 per share.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American rules.
- Original note principal was $3,301,250; exchange reduces outstanding balance by $450,000.
- Shares issued under Section 3(a)(9) exemption; no commission paid.

## SEC filing metadata
- accession: 0001493152-26-042196
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-09-10T20:35:30+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/0001493152-26-042196-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042196
- JSON: https://secwatch.observer/filing/0001493152-26-042196.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042196.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.